Vectors Research Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Vectors Research Management's GILD Position: Q2 2024 in Review
Vectors Research Management sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 9,189 shares — an estimated $673K sold.
Vectors Research Management first reported a position in GILD in Q3 2018 and held it in 23 quarters. The position peaked at $883K in Q4 2022. 1,678 funds tracked by Wall St. Rank hold GILD as of Q2 2024.
- Vectors Research Management reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
- Vectors Research Management sold 9,189 Gilead Sciences shares in Q2 2024, an estimated $673K.
- Vectors Research Management first reported a position in Gilead Sciences in Q3 2018 and held it in 23 quarters.
- Vectors Research Management's Gilead Sciences position peaked at $883K in Q4 2022.
- 1,678 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.
Based on Vectors Research Management's 13F filing for Q2 2024, filed 9 Aug 2024.